Published in
American Society for Clinical Investigation, JCI Insight, 17(5), 2020
DOI: 10.1172/jci.insight.140532
Links
Tools
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Journal article published in 2020 by
Francis S. Willard 
,
Jonathan D. Douros ,
Maria B. N. Gabe,
Aaron D. Showalter,
David B. Wainscott,
Todd M. Suter,
Megan E. Capozzi ,
Wijnand J. C. van der Velden ,
Cynthia Stutsman,
Guemalli R. Cardona,
Shweta Urva ,
Paul J. Emmerson,
Jens J. Holst ,
David A. D'Alessio ,
David A. D’Alessio
and other authors.
,
Jonathan D. Douros ,
Maria B. N. Gabe,
Aaron D. Showalter,
David B. Wainscott,
Todd M. Suter,
Megan E. Capozzi ,
Wijnand J. C. van der Velden ,
Cynthia Stutsman,
Guemalli R. Cardona,
Shweta Urva ,
Paul J. Emmerson,
Jens J. Holst ,
David A. D'Alessio ,
David A. D’Alessio
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 